Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Scarbrough PM, Weber RP, Iversen ES, Brhane Y, Amos CI, Kraft P, Hung RJ, Sellers TA, Witte JS, Pharoah P, Henderson BE, Gruber SB, Hunter DJ, Garber JE, Joshi AD, McDonnell K, Easton DF, Eeles R, Kote-Jarai Z, Muir K, Doherty JA, Schildkraut JM.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):193-200. doi: 10.1158/1055-9965.EPI-15-0649. Epub 2015 Dec 4.

2.

Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.

Siamakpour-Reihani S, Owzar K, Jiang C, Scarbrough PM, Craciunescu OI, Horton JK, Dressman HK, Blackwell KL, Dewhirst MW.

Int J Hyperthermia. 2015 Jun;31(4):386-95. doi: 10.3109/02656736.2015.1016557. Epub 2015 Mar 26.

3.

Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise.

Betof AS, Lascola CD, Weitzel D, Landon C, Scarbrough PM, Devi GR, Palmer G, Jones LW, Dewhirst MW.

J Natl Cancer Inst. 2015 Mar 16;107(5). pii: djv040. doi: 10.1093/jnci/djv040. Print 2015 May.

4.

Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.

Li L, Fath MA, Scarbrough PM, Watson WH, Spitz DR.

Redox Biol. 2015;4:127-35. doi: 10.1016/j.redox.2014.12.001. Epub 2014 Dec 10.

5.

Exploring the association between melanoma and glioma risks.

Scarbrough PM, Akushevich I, Wrensch M, Il'yasova D.

Ann Epidemiol. 2014 Jun;24(6):469-74. doi: 10.1016/j.annepidem.2014.02.010. Epub 2014 Mar 4.

6.

Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer.

Kennedy KM, Scarbrough PM, Ribeiro A, Richardson R, Yuan H, Sonveaux P, Landon CD, Chi JT, Pizzo S, Schroeder T, Dewhirst MW.

PLoS One. 2013 Sep 12;8(9):e75154. doi: 10.1371/journal.pone.0075154. eCollection 2013.

7.

Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.

Speicher PJ, Beasley GM, Jiang B, Lidsky ME, Palmer GM, Scarbrough PM, Mosca PJ, Dewhirst MW, Tyler DS.

Ann Surg Oncol. 2014 May;21(5):1435-40. doi: 10.1245/s10434-013-3222-0. Epub 2013 Aug 28.

8.

Systemic oxidative stress, as measured by urinary allantoin and F(2)-isoprostanes, is not increased in Down syndrome.

Tolun AA, Scarbrough PM, Zhang H, McKillop JA, Wang F, Kishnani PS, Millington DS, Young SP, Il'yasova D.

Ann Epidemiol. 2012 Dec;22(12):892-4. doi: 10.1016/j.annepidem.2012.09.005. Epub 2012 Oct 11.

9.

Systemic markers of oxidative status and colorectal adenomatous polyps.

Siamakpour-Reihani S, Scarbrough PM, Wang F, Spasojevic I, Base K, Sedjo R, D'Agostino RB Jr, Il'yasova D.

Ann Epidemiol. 2012 Aug;22(8):587-91. doi: 10.1016/j.annepidem.2012.05.001. Epub 2012 Jun 12.

10.

Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.

Scarbrough PM, Mapuskar KA, Mattson DM, Gius D, Watson WH, Spitz DR.

Free Radic Biol Med. 2012 Jan 15;52(2):436-43. doi: 10.1016/j.freeradbiomed.2011.10.493. Epub 2011 Nov 4.

11.

Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4.

Orcutt KP, Parsons AD, Sibenaller ZA, Scarbrough PM, Zhu Y, Sobhakumari A, Wilke WW, Kalen AL, Goswami P, Miller FJ Jr, Spitz DR, Simons AL.

Cancer Res. 2011 Jun 1;71(11):3932-40. doi: 10.1158/0008-5472.CAN-10-3425. Epub 2011 Apr 11.

Supplemental Content

Loading ...
Support Center